SlideShare una empresa de Scribd logo
1 de 16
Descargar para leer sin conexión
   Set up in 2009 by a group of Parents all of which met
    through the Yahoo Group for CDKL5 Parents
   Current Board of Directors
    ◦ Katheryn Frame – President, Melissa Ralston –
      Secretary, Karen Utley – Treasurer, Kelly Barnes,
      Kristin Leopoldino, Kimberley Nothurft, Carol-Anne
      Partridge
   Scientific Advisory Board
    ◦ David Frame, PhD, University of Michigan
    ◦ Dr Sumit Parikh, MD, The Cleveland Clinic
    ◦ Dr Walter E Kauffman MD, John Hopkins/Kennedy
      Krieger
“To lead the way in finding a cure and treatments for CDKL5
 disorders by funding global research efforts, and increasing
awareness of CDKL5 disorders, while enhancing the quality of
   life for those affected by CDKL5 disorders, by providing
              information, programs, and services”

   How are we achieving
          this?
   Committed band of Parents and families
    raising vast amounts of money collectively
    ◦ From small events to large events
   Pepsi Grant – for iPS Cells with remainder
    used to create video/media
   IFCR Shop – www.cdkl5.com
   Registration to become Partner, Active
    Partner attracting a $20 donation which
    attracts benefit, or corresponding partner
   Induced Pluripotent Stem Cells (iPS)
    ◦ Fibroblasts derived from Skin Cells
       Taken 6 affected Boys with CDKL5
       One girl with a specific CDKL5 mutation
    ◦ Pluripotent – Means the ability to grow into any cell
      in the body including Neurons
    ◦ The IFCR is currently working with Dr Alysson
      Muotri at the University of California in San Diego,
      who is having success with several lines


So where are we today?
   Development of Knock-out Mouse Model -
    ◦ Knock-out Mouse, genetically created without the
      CDKL5 Gene
    ◦ Critical in studying disorders like CDKL5
    ◦ Co-funded with International Rett Syndrome
      Foundation
    ◦ Funding – Dr Cornelius Gross and his fellow Dr
      Elena Amendola – Italy
       Currently FDA mandates that new drugs be tested
        on animal models with positive results before
        human trials are allowed

So where are we today?
   Second Mouse Model
    ◦ Knock-in Mouse
    ◦ Specific Non-sense mutation (R59X) seen in at least
      5 children with CDKL5 (including one boy)
    ◦ Will be used in conjunction with iPS lines created by
      2 children with R59X mutation one boy and one girl
    ◦ Benefits –
       New drugs already being developed
       Ability to test to see affects on mice and potential
        therapeutic and developmental gains for our
        children
    ◦ Funding – Dr Joe Zhou from the University of
      Pennsylvania

So where are we today?
   An IFCR Part-Funded Initiative
   Little is known about the natural history and
    occurrence of the CDKL5 disorder
   A group of researchers in Australia in
    collaboration with the International Foundation
    for CDKL5 Research are planning on developing
    an International Register for the CDKL5 Disorder
   They hope that this register will allow the
    collection of better information on the CDKL5
    disorder from families and their clinician across
    the world
   If you are interested in participating you can complete a
    questionnaire through the International Rett Syndrome
    Phenotype Database (InterRett) or contact them on
    • Website:
      https://interrett.ichr.uwa.edu.au//?q=/rett/irsa/
    • Email: CDKL5@ichr.uwa.edu.au
    • Phone: +61 419956946
   A new questionnaire is being developed and will be
    available for completion in early 2012.
   There will also be follow-up questionnaires on a yearly
    basis and the potential for sharing video information.
   Charitable Fund
    ◦ Operating within Rett UK
    ◦ An Alliance with Rett UK and the IFCR
   Aims
    ◦ To raise the profile and awareness of the condition
      in the UK and worldwide
    ◦ To reach out to families in the UK living with the
      diagnosis of CDKL5
    ◦ To fundraise for research for the IFCR
    ◦ To collaborate with Rett UK and the IFCR to create a
      signposting support structure
   http://uk.groups.yahoo.com/group/CDKL5
The first parent support group set up by a UK
mum in 2005. A closed group accessed by request or
by invitation has around 160 global members to
date. Including Professor Christodoulou who is
involved in vital research into CDKL5
   www.cdkl5.com
The birth of the International Foundation for CDKL5
Research, started by US and Leita Boltwood, from
Australia families brought together by the yahoo
parent support group
   https://www.facebook.com/groups/CDKL5
CDKL5 Parents Support Group
   https://www.facebook.com/groups/11327098209
    0227/
CDKL5 Siblings Support Group
 Support   you can touch….
   Raising Awareness
   Fundraising
   Finding other affected families
   Allowing our children to flourish
      “………and so here we are, giving hope through
    research and support to families within the UK living with
    CDKL5”
For them….




‘So…...keep facing the sun and the
Shadows of life will always be behind you’

Más contenido relacionado

Similar a CDKL5 UK[1]

World Fertility Day.docx
World Fertility Day.docxWorld Fertility Day.docx
World Fertility Day.docx9M Fertility
 
Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...
Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...
Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...Department of Health
 
Global Health in the 21st Century
Global Health in the 21st CenturyGlobal Health in the 21st Century
Global Health in the 21st Centurytombesam
 
Why there needs to be open data for ultra-rare and rare disease drug discovery
Why there needs to be open data for ultra-rare and rare disease drug discoveryWhy there needs to be open data for ultra-rare and rare disease drug discovery
Why there needs to be open data for ultra-rare and rare disease drug discoverySean Ekins
 
Dr Roy Philip , Paediatrician, Neonatologist and an innovator of healthcare p...
Dr Roy Philip , Paediatrician, Neonatologist and an innovator of healthcare p...Dr Roy Philip , Paediatrician, Neonatologist and an innovator of healthcare p...
Dr Roy Philip , Paediatrician, Neonatologist and an innovator of healthcare p...Investnet
 
CASE 12 Nestlé The Infant Formula Controversy largel.docx
    CASE 12 Nestlé The Infant Formula Controversy largel.docx    CASE 12 Nestlé The Infant Formula Controversy largel.docx
CASE 12 Nestlé The Infant Formula Controversy largel.docxhallettfaustina
 
Every Preemie – Scale: Scaling, Catalyzing, Advocating, Learning, Evidence-Dr...
Every Preemie – Scale: Scaling, Catalyzing, Advocating, Learning, Evidence-Dr...Every Preemie – Scale: Scaling, Catalyzing, Advocating, Learning, Evidence-Dr...
Every Preemie – Scale: Scaling, Catalyzing, Advocating, Learning, Evidence-Dr...CORE Group
 
CJMLS_Summer2016_ENG_article only copy
CJMLS_Summer2016_ENG_article only copyCJMLS_Summer2016_ENG_article only copy
CJMLS_Summer2016_ENG_article only copyJane Langille
 
Nestle-the-infant-formula-controversy (1)
Nestle-the-infant-formula-controversy (1)Nestle-the-infant-formula-controversy (1)
Nestle-the-infant-formula-controversy (1)Obydull Akbar
 
Rheumatic Heart Disease Australia TableTop Session
Rheumatic Heart Disease Australia TableTop SessionRheumatic Heart Disease Australia TableTop Session
Rheumatic Heart Disease Australia TableTop SessionNACCHOpresentations
 
Sub-regional and Global SCD Networks - Jacques Elion
Sub-regional and Global SCD Networks - Jacques ElionSub-regional and Global SCD Networks - Jacques Elion
Sub-regional and Global SCD Networks - Jacques ElionHuman Variome Project
 
Activities of the March of Dimes - Joe Leigh Simpson
Activities of the March of Dimes - Joe Leigh SimpsonActivities of the March of Dimes - Joe Leigh Simpson
Activities of the March of Dimes - Joe Leigh SimpsonHuman Variome Project
 
ETHICAL ISSUES IN REPRODUCTIVE TECHNOLOGY AND ORGAN TRANSPLANTATION
ETHICAL ISSUES IN REPRODUCTIVE TECHNOLOGY AND ORGAN TRANSPLANTATIONETHICAL ISSUES IN REPRODUCTIVE TECHNOLOGY AND ORGAN TRANSPLANTATION
ETHICAL ISSUES IN REPRODUCTIVE TECHNOLOGY AND ORGAN TRANSPLANTATIONaswathy krishna
 
Thinking critically-session-1
Thinking critically-session-1Thinking critically-session-1
Thinking critically-session-1Simon Phipp
 
Breastfeeding-Nature's Best
Breastfeeding-Nature's BestBreastfeeding-Nature's Best
Breastfeeding-Nature's Bestmilfamln
 

Similar a CDKL5 UK[1] (20)

World Fertility Day.docx
World Fertility Day.docxWorld Fertility Day.docx
World Fertility Day.docx
 
Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...
Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...
Global Dementia Legacy Event: Ms Inez Jabalpurwala, President and CEO, Brain ...
 
Day 1: Children's Healthcare Canada CORD
Day 1: Children's Healthcare Canada CORD Day 1: Children's Healthcare Canada CORD
Day 1: Children's Healthcare Canada CORD
 
Global Health in the 21st Century
Global Health in the 21st CenturyGlobal Health in the 21st Century
Global Health in the 21st Century
 
Why there needs to be open data for ultra-rare and rare disease drug discovery
Why there needs to be open data for ultra-rare and rare disease drug discoveryWhy there needs to be open data for ultra-rare and rare disease drug discovery
Why there needs to be open data for ultra-rare and rare disease drug discovery
 
Childhood Cancer Awareness - CANSA 2017
Childhood Cancer Awareness - CANSA 2017Childhood Cancer Awareness - CANSA 2017
Childhood Cancer Awareness - CANSA 2017
 
Dr Roy Philip , Paediatrician, Neonatologist and an innovator of healthcare p...
Dr Roy Philip , Paediatrician, Neonatologist and an innovator of healthcare p...Dr Roy Philip , Paediatrician, Neonatologist and an innovator of healthcare p...
Dr Roy Philip , Paediatrician, Neonatologist and an innovator of healthcare p...
 
CASE 12 Nestlé The Infant Formula Controversy largel.docx
    CASE 12 Nestlé The Infant Formula Controversy largel.docx    CASE 12 Nestlé The Infant Formula Controversy largel.docx
CASE 12 Nestlé The Infant Formula Controversy largel.docx
 
Every Preemie – Scale: Scaling, Catalyzing, Advocating, Learning, Evidence-Dr...
Every Preemie – Scale: Scaling, Catalyzing, Advocating, Learning, Evidence-Dr...Every Preemie – Scale: Scaling, Catalyzing, Advocating, Learning, Evidence-Dr...
Every Preemie – Scale: Scaling, Catalyzing, Advocating, Learning, Evidence-Dr...
 
GMRF Annual Report 2015
GMRF Annual Report 2015 GMRF Annual Report 2015
GMRF Annual Report 2015
 
CJMLS_Summer2016_ENG_article only copy
CJMLS_Summer2016_ENG_article only copyCJMLS_Summer2016_ENG_article only copy
CJMLS_Summer2016_ENG_article only copy
 
Nestle-the-infant-formula-controversy (1)
Nestle-the-infant-formula-controversy (1)Nestle-the-infant-formula-controversy (1)
Nestle-the-infant-formula-controversy (1)
 
Rheumatic Heart Disease Australia TableTop Session
Rheumatic Heart Disease Australia TableTop SessionRheumatic Heart Disease Australia TableTop Session
Rheumatic Heart Disease Australia TableTop Session
 
Sub-regional and Global SCD Networks - Jacques Elion
Sub-regional and Global SCD Networks - Jacques ElionSub-regional and Global SCD Networks - Jacques Elion
Sub-regional and Global SCD Networks - Jacques Elion
 
Fha hero
Fha heroFha hero
Fha hero
 
Activities of the March of Dimes - Joe Leigh Simpson
Activities of the March of Dimes - Joe Leigh SimpsonActivities of the March of Dimes - Joe Leigh Simpson
Activities of the March of Dimes - Joe Leigh Simpson
 
ETHICAL ISSUES IN REPRODUCTIVE TECHNOLOGY AND ORGAN TRANSPLANTATION
ETHICAL ISSUES IN REPRODUCTIVE TECHNOLOGY AND ORGAN TRANSPLANTATIONETHICAL ISSUES IN REPRODUCTIVE TECHNOLOGY AND ORGAN TRANSPLANTATION
ETHICAL ISSUES IN REPRODUCTIVE TECHNOLOGY AND ORGAN TRANSPLANTATION
 
WIRF feature
WIRF featureWIRF feature
WIRF feature
 
Thinking critically-session-1
Thinking critically-session-1Thinking critically-session-1
Thinking critically-session-1
 
Breastfeeding-Nature's Best
Breastfeeding-Nature's BestBreastfeeding-Nature's Best
Breastfeeding-Nature's Best
 

Último

Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYKayeClaireEstoconing
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)lakshayb543
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
FILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinoFILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinojohnmickonozaleda
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Mark Reed
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)cama23
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptxiammrhaywood
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...JhezDiaz1
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...Nguyen Thanh Tu Collection
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17Celine George
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxAnupkumar Sharma
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfJemuel Francisco
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxiammrhaywood
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 

Último (20)

Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
 
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
Visit to a blind student's school🧑‍🦯🧑‍🦯(community medicine)
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
FILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipinoFILIPINO PSYCHology sikolohiyang pilipino
FILIPINO PSYCHology sikolohiyang pilipino
 
Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)Influencing policy (training slides from Fast Track Impact)
Influencing policy (training slides from Fast Track Impact)
 
Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)Global Lehigh Strategic Initiatives (without descriptions)
Global Lehigh Strategic Initiatives (without descriptions)
 
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptxAUDIENCE THEORY -CULTIVATION THEORY -  GERBNER.pptx
AUDIENCE THEORY -CULTIVATION THEORY - GERBNER.pptx
 
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
ENGLISH 7_Q4_LESSON 2_ Employing a Variety of Strategies for Effective Interp...
 
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
HỌC TỐT TIẾNG ANH 11 THEO CHƯƠNG TRÌNH GLOBAL SUCCESS ĐÁP ÁN CHI TIẾT - CẢ NĂ...
 
How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17How to Add Barcode on PDF Report in Odoo 17
How to Add Barcode on PDF Report in Odoo 17
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
Raw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptxRaw materials used in Herbal Cosmetics.pptx
Raw materials used in Herbal Cosmetics.pptx
 
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptxMULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
MULTIDISCIPLINRY NATURE OF THE ENVIRONMENTAL STUDIES.pptx
 
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdfGrade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
Grade 9 Quarter 4 Dll Grade 9 Quarter 4 DLL.pdf
 
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptxECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
ECONOMIC CONTEXT - PAPER 1 Q3: NEWSPAPERS.pptx
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 

CDKL5 UK[1]

  • 1.
  • 2. Set up in 2009 by a group of Parents all of which met through the Yahoo Group for CDKL5 Parents  Current Board of Directors ◦ Katheryn Frame – President, Melissa Ralston – Secretary, Karen Utley – Treasurer, Kelly Barnes, Kristin Leopoldino, Kimberley Nothurft, Carol-Anne Partridge  Scientific Advisory Board ◦ David Frame, PhD, University of Michigan ◦ Dr Sumit Parikh, MD, The Cleveland Clinic ◦ Dr Walter E Kauffman MD, John Hopkins/Kennedy Krieger
  • 3. “To lead the way in finding a cure and treatments for CDKL5 disorders by funding global research efforts, and increasing awareness of CDKL5 disorders, while enhancing the quality of life for those affected by CDKL5 disorders, by providing information, programs, and services” How are we achieving this?
  • 4. Committed band of Parents and families raising vast amounts of money collectively ◦ From small events to large events  Pepsi Grant – for iPS Cells with remainder used to create video/media  IFCR Shop – www.cdkl5.com  Registration to become Partner, Active Partner attracting a $20 donation which attracts benefit, or corresponding partner
  • 5. Induced Pluripotent Stem Cells (iPS) ◦ Fibroblasts derived from Skin Cells  Taken 6 affected Boys with CDKL5  One girl with a specific CDKL5 mutation ◦ Pluripotent – Means the ability to grow into any cell in the body including Neurons ◦ The IFCR is currently working with Dr Alysson Muotri at the University of California in San Diego, who is having success with several lines So where are we today?
  • 6. Development of Knock-out Mouse Model - ◦ Knock-out Mouse, genetically created without the CDKL5 Gene ◦ Critical in studying disorders like CDKL5 ◦ Co-funded with International Rett Syndrome Foundation ◦ Funding – Dr Cornelius Gross and his fellow Dr Elena Amendola – Italy  Currently FDA mandates that new drugs be tested on animal models with positive results before human trials are allowed So where are we today?
  • 7. Second Mouse Model ◦ Knock-in Mouse ◦ Specific Non-sense mutation (R59X) seen in at least 5 children with CDKL5 (including one boy) ◦ Will be used in conjunction with iPS lines created by 2 children with R59X mutation one boy and one girl ◦ Benefits –  New drugs already being developed  Ability to test to see affects on mice and potential therapeutic and developmental gains for our children ◦ Funding – Dr Joe Zhou from the University of Pennsylvania So where are we today?
  • 8. An IFCR Part-Funded Initiative  Little is known about the natural history and occurrence of the CDKL5 disorder  A group of researchers in Australia in collaboration with the International Foundation for CDKL5 Research are planning on developing an International Register for the CDKL5 Disorder  They hope that this register will allow the collection of better information on the CDKL5 disorder from families and their clinician across the world
  • 9. If you are interested in participating you can complete a questionnaire through the International Rett Syndrome Phenotype Database (InterRett) or contact them on • Website: https://interrett.ichr.uwa.edu.au//?q=/rett/irsa/ • Email: CDKL5@ichr.uwa.edu.au • Phone: +61 419956946  A new questionnaire is being developed and will be available for completion in early 2012.  There will also be follow-up questionnaires on a yearly basis and the potential for sharing video information.
  • 10.
  • 11. Charitable Fund ◦ Operating within Rett UK ◦ An Alliance with Rett UK and the IFCR  Aims ◦ To raise the profile and awareness of the condition in the UK and worldwide ◦ To reach out to families in the UK living with the diagnosis of CDKL5 ◦ To fundraise for research for the IFCR ◦ To collaborate with Rett UK and the IFCR to create a signposting support structure
  • 12. http://uk.groups.yahoo.com/group/CDKL5 The first parent support group set up by a UK mum in 2005. A closed group accessed by request or by invitation has around 160 global members to date. Including Professor Christodoulou who is involved in vital research into CDKL5  www.cdkl5.com The birth of the International Foundation for CDKL5 Research, started by US and Leita Boltwood, from Australia families brought together by the yahoo parent support group
  • 13. https://www.facebook.com/groups/CDKL5 CDKL5 Parents Support Group  https://www.facebook.com/groups/11327098209 0227/ CDKL5 Siblings Support Group
  • 14.  Support you can touch….
  • 15. Raising Awareness  Fundraising  Finding other affected families  Allowing our children to flourish “………and so here we are, giving hope through research and support to families within the UK living with CDKL5”
  • 16. For them…. ‘So…...keep facing the sun and the Shadows of life will always be behind you’